← Leaderboards
Terry B Gernsheimer
University Of Washington
$5,994,580
Attributed
$5,994,580
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2015–19$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,994,580 · 1
By mechanism
U01$5,994,580 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Hans D Ochs$9,229,500
- Janet S Lee$14,899,810
- Kenneth E. Thummel$18,445,737
- Alexander P Reiner$25,408,009
- Alexander St. John$779,225
Others in their field
Top investigators on “6-Aminocaproic Acid”
- Paul E. Bock · Vanderbilt University$1,640,369
- Ellis J Neufeld · Children'S Hospital Boston$1,003,250
- Scott S Emerson · University Of Washington$961,582
- Susanne May · University Of California, San Diego$953,740
- Sean Crosson · Stanford University$455,500
- M. Ashfaqul Alam · Emory University$375,080
Research focus
6-Aminocaproic AcidAffectAdoptedAntifibrinolytic AgentsBlood CoagulationBlood PlateletsBone Marrow DiseasesBone Marrow TransplantationChemotherapyClinicClinical TrialsCoagulation ProcessCritical IllnessDefectDiariesDoseDouble-Blind MethodEconomic ImpactEligibility DeterminationErythrocyte TransfusionEventFibrinolysisFibrinolytic AgentsHealth Care Costs
Grant awards (5)
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)$885,149
U01 · FY2019 · HL · contact PI
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)$1,190,601
U01 · FY2018 · HL · contact PI
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)$1,502,614
U01 · FY2017 · HL · contact PI
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)$1,170,205
U01 · FY2016 · HL · contact PI
American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)$1,246,011
U01 · FY2015 · HL · contact PI